Kevin Asher, BPharm
Vice President, Global Head of Medical Strategy and Innovation/ Allergan
Kevin is a UK qualified pharmacist with nearly 15 years experience in medical affairs internationally. He has grown his career within medical affairs from an MSL role within the UK to building an International team of 200. Kevin worked on the integration and building of a new Medical department following the acquisition of Allergan by Actavis and on the separation of a Medical department following the divestiture of the Allergan generics business to Teva. Most recently Kevin has been working on bold proposals to reshape how Medical Affairs will adapt to the changing healthcare and consumer markets as peoples’ expectations rapidly evolve.